Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2004
04/28/2004EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
04/28/2004EP1263714B1 Novel phenylheteroalkylamine derivatives
04/28/2004EP1228062B1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridines
04/28/2004EP1089975B1 Improved method for producing substituted pyridine-carboxylic acids
04/28/2004EP1051394B1 Potassium channel inhibitors
04/28/2004EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
04/28/2004EP0888271B1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
04/28/2004EP0881267B1 Azo compounds and process for preparing the same
04/28/2004EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them
04/28/2004CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor
04/28/2004CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
04/28/2004CN1492851A Method for synthesizing camptothecin-relating compounds
04/28/2004CN1491943A Process for preparing 4-substituted pyridine compound
04/28/2004CN1491937A 农药 Pesticide
04/28/2004CN1147474C Process for the preparation of 2-cyanopyridines
04/28/2004CN1147473C Process for preparing tribomomethylsulfonylphyridine
04/28/2004CN1147472C Benzamide formulation with histone deacetylase inhibitor activity
04/28/2004CN1147469C Novel urea derivatives bearing nitrogenous aromatic heterocycles
04/28/2004CN1147294C Pentafluorobenzenesulfonamides and analogs
04/27/2004US6727392 Such as 4b(s)-benzyl-7(s)-hydroxy-7(s)-(3,3,3-trifluoropropyl)4,5,6,7,8,8a(r),9,10 -octahydro-phenanthrene-2-carboxylic acid (2-methyl-pyridin-3-ylmethyl)-amide via catalytic reduction; transcription factors
04/27/2004US6727377 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes
04/27/2004US6727365 Process for the preparation of vinylpyridine from picoline over modified zeolites
04/27/2004US6727361 Phosphino substituted pyridine amine ligands
04/27/2004US6727318 Method for producing aqueous polymer dispersions containing colorants
04/27/2004US6727265 Reverse transcriptase inhibitors for drug resistant patients
04/27/2004US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
04/27/2004US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros)
04/27/2004US6727237 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate
04/27/2004US6726894 Transport vehicles for macromolecules
04/22/2004WO2004033450A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
04/22/2004WO2004033444A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
04/22/2004WO2004033436A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
04/22/2004WO2004033430A2 Process for production of fluoroalkoxy-substituted benzamides and their intermediates
04/22/2004WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity
04/22/2004WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
04/22/2004WO2004032933A1 Method for treatment of cancer
04/22/2004WO2004032908A2 Method of inhibiting angiogenesis
04/22/2004WO2004026806A3 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent
04/22/2004WO2004020416A3 Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides
04/22/2004WO2004016597A3 Protein kinase inhibitors and uses thereof
04/22/2004WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
04/22/2004WO2004005407A3 Tetra-azapentamethine and use thereof for dyeing keratinous fibers
04/22/2004WO2003041728A9 Novel phenyl-propargylether derivatives
04/22/2004WO2000061134A9 Antimicrobial agents
04/22/2004US20040077896 Compounds for the treatment of metabolic disorders
04/22/2004US20040077890 Complexed compounds and use thereof for the polymerisation of olefins
04/22/2004US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer
04/22/2004US20040077872 Palladium salt without a ligand being used as palladium catalyst; cheap, simple and commercially attractive process involving an optionally substituted aromatic bromide
04/22/2004US20040077871 Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists
04/22/2004US20040077868 Process
04/22/2004US20040077867 Amine compounds, their production and use
04/22/2004US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector
04/22/2004US20040077853 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
04/22/2004US20040077846 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process
04/22/2004US20040077726 Antiproliferative and anticarcinogenic agents; psoriasis
04/22/2004US20040077690 Anticoagulants; cardiovascular and brain disorders
04/22/2004US20040077646 Indole nitriles
04/22/2004US20040077635 Trypsin-like serine protease inhibitors; treating thromboembolic disorders; anticoagulants
04/22/2004US20040077620 Hypoglycemic agent
04/22/2004US20040077600 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
04/22/2004US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release
04/22/2004US20040077489 Polymerisation catalysts
04/22/2004US20040077487 Complex catalyst, process for producing the complex catalyst, and process for producing alchohol derivative with the complex catalyst
04/22/2004US20040076673 Oral pharmaceutical composition containing a block copolymer
04/22/2004US20040075096 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
04/22/2004US20040074842 Filtration; for prevention of destruction of catalyst
04/22/2004DE10247578A1 Functionalized ionic liquids obtained by a new, more efficient and low-cost method, used as solvents in catalytic reactions or as extractants, entrainers, wash liquids, heat transfer media, surfactants, modifiers and plasticisers
04/22/2004CA2501801A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
04/22/2004CA2501534A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
04/22/2004CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity
04/22/2004CA2501043A1 Method of inhibiting angiogenesis
04/22/2004CA2499642A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
04/21/2004EP1411053A1 Method for obtaining derivatives of (pyridil substituted)methyl]thio]benzimidazol
04/21/2004EP1411049A1 Estrogen Agonists/Antagonists
04/21/2004EP1409468A2 Guanidinobenzamides as mc4-r agonists
04/21/2004EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
04/21/2004EP1409460A1 Novel synthesis of heteroarylamine intermediate compounds
04/21/2004EP1409459A2 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
04/21/2004EP1409456A2 Detection of transmembrane potentials by optical methods
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1409440A1 A method to inhibit ethylene responses in plants
04/21/2004EP1408986A2 Proteomimetic compounds and methods
04/21/2004EP1408966A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
04/21/2004EP1408962A1 Substituted isoindoles and the use thereof
04/21/2004EP1408919A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye
04/21/2004EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
04/21/2004EP1154987B1 Phenylalaninol derivatives
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491237A Complexed compounds and use thereof for polymerization of olefins
04/21/2004CN1491214A Process and catalyst for preparation of acetylpyridines
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1491200A Process for manufacture of phenylacetic acid derivatives
04/21/2004CN1490313A Preparation of 3-cyanopyridine
04/21/2004CN1146560C Substituted benzoylpyrazoles as herbicides
04/21/2004CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof
04/21/2004CN1146542C Benzamide derivatives and their use as cytokine inhibitors
04/21/2004CN1146541C Beta-alanine derivatives
04/21/2004CN1146540C Novel compound with analgesic effect and use thereof
04/21/2004CN1146536C Cycloethylene derivatives